{"disease":{"id":"secondary-primary-malignancies-after-retinoblastoma","name":"secondary primary malignancies after retinoblastoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04164134","title":"New Strategies to Detect Cancers in Carriers of Mutations in RB1","phase":"","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}